Comments
Torrent Pharmaceuticals Ltd shares gained 3.5 per cent, while Alembic Pharmaceuticals Ltd gained over 6 per cent following USFDA approval for generic versions of blockbuster antipsychotic drug Abilify.
Torrent, Alembic, Hetero Labs and Teva Pharmaceutical Industries Ltd have received the drug regulator's approval.
The product can generate $35-50 million in annualised sales for each company, with high margins, brokerage Motilal Oswal said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.